Ranbaxy Labs

CCI says Sun-Ranbaxy deal may hit competition; seeks comments

New Delhi: Launching the first-ever public scrutiny of an M&A deal in India, fair trade watchdog CCI today said it has prima facie found that the USD 4-billion merger of Ranbaxy Labs into rival Sun